Cargando…

Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)

Detalles Bibliográficos
Autores principales: Barratt, Jonathan, Rovin, Brad, Diva, Ulysses, Mercer, Alex, Komers, Radko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933476/
https://www.ncbi.nlm.nih.gov/pubmed/31891005
http://dx.doi.org/10.1016/j.ekir.2019.08.007
_version_ 1783483223427252224
author Barratt, Jonathan
Rovin, Brad
Diva, Ulysses
Mercer, Alex
Komers, Radko
author_facet Barratt, Jonathan
Rovin, Brad
Diva, Ulysses
Mercer, Alex
Komers, Radko
author_sort Barratt, Jonathan
collection PubMed
description
format Online
Article
Text
id pubmed-6933476
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69334762019-12-30 Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial) Barratt, Jonathan Rovin, Brad Diva, Ulysses Mercer, Alex Komers, Radko Kidney Int Rep Research Letter Elsevier 2019-08-19 /pmc/articles/PMC6933476/ /pubmed/31891005 http://dx.doi.org/10.1016/j.ekir.2019.08.007 Text en © 2019 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Barratt, Jonathan
Rovin, Brad
Diva, Ulysses
Mercer, Alex
Komers, Radko
Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
title Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
title_full Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
title_fullStr Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
title_full_unstemmed Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
title_short Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
title_sort implementing the kidney health initiative surrogate efficacy endpoint in patients with iga nephropathy (the protect trial)
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933476/
https://www.ncbi.nlm.nih.gov/pubmed/31891005
http://dx.doi.org/10.1016/j.ekir.2019.08.007
work_keys_str_mv AT barrattjonathan implementingthekidneyhealthinitiativesurrogateefficacyendpointinpatientswithiganephropathytheprotecttrial
AT rovinbrad implementingthekidneyhealthinitiativesurrogateefficacyendpointinpatientswithiganephropathytheprotecttrial
AT divaulysses implementingthekidneyhealthinitiativesurrogateefficacyendpointinpatientswithiganephropathytheprotecttrial
AT merceralex implementingthekidneyhealthinitiativesurrogateefficacyendpointinpatientswithiganephropathytheprotecttrial
AT komersradko implementingthekidneyhealthinitiativesurrogateefficacyendpointinpatientswithiganephropathytheprotecttrial
AT implementingthekidneyhealthinitiativesurrogateefficacyendpointinpatientswithiganephropathytheprotecttrial